Philip Morris International Announces U.S. FDA Reauthorization of IQOS as a Modified Risk Tobacco Product
· Financial Post
STAMFORD, CT -- The U.S. Food and Drug Administration (FDA) announced that it has authorized the renewal of modified risk tobacco product (MRTP) orders previously granted to PMI for two versions of the IQOS device and three variants of the tobacco consumables, commercialized under the HEETS brand. This renewal allows PMI to continue sharing reduced-exposure information with U.S. adults 21+ who use traditional tobacco products, such as combustible cigarettes. Read More
Visit grenadier.co.za for more information.